Susquehanna International Group, LLP Unity Biotechnology, Inc. Transaction History

Susquehanna International Group, LLP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.56 - $1.29 $79,712 - $183,623	-142,344 Reduced 75.76%	45,551 $26,000
Q1 2022 May 16, 2022	SELL	$0.72 - $1.86 $118,170 - $305,274	-164,126 Reduced 46.62%	187,895 $211,000
Q4 2021 Feb 14, 2022	BUY	$1.3 - $3.17 $167,672 - $408,863	128,979 Added 57.83%	352,021 $514,000
Q3 2021 Nov 15, 2021	BUY	$2.91 - $4.5 $412,728 - $638,239	141,831 Added 174.65%	223,042 $669,000
Q2 2021 Aug 11, 2021	BUY	$4.15 - $6.3 $84,913 - $128,904	20,461 Added 33.68%	81,211 $377,000
Q1 2021 May 17, 2021	SELL	$5.51 - $9.42 $180,199 - $308,071	-32,704 Reduced 34.99%	60,750 $365,000
Q4 2020 Feb 16, 2021	BUY	$3.42 - $6.36 $233,486 - $434,203	68,271 Added 271.1%	93,454 $490,000
Q3 2020 Nov 16, 2020	BUY	$2.94 - $12.43 $40,868 - $172,789	13,901 Added 123.21%	25,183 $87,000
Q2 2020 Aug 14, 2020	SELL	$5.28 - $9.67 $53,232 - $97,492	-10,082 Reduced 47.19%	11,282 $98,000
Q1 2020 May 15, 2020	BUY	$5.0 - $7.6 $106,820 - $162,366	21,364 New	21,364 $124,000
Q4 2019 Feb 14, 2020	SELL	$5.99 - $8.38 $82,404 - $115,283	-13,757 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$5.62 - $9.63 $20,777 - $35,602	-3,697 Reduced 21.18%	13,757 $84,000
Q2 2019 Aug 16, 2019	BUY	$7.59 - $10.21 $49,631 - $66,763	6,539 Added 59.91%	17,454 $166,000
Q4 2018 Feb 14, 2019	BUY	$10.76 - $17.25 $117,445 - $188,283	10,915 New	10,915 $177,000

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $20.6M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.